UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

BMC pulmonary medicine, 2010-08, Vol.10 (1), p.45-45, Article 45

2010

Volltextzugriff (PDF)

GASTROINTESTINAL CONDITIONS AMONG PATIENTS WITH ATRIAL FIBRILLATION

Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E616-E616

2012

Volltextzugriff (PDF)

Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism

Journal of medical economics, 2014-01, Vol.17 (1), p.52-64

2014

Volltextzugriff (PDF)

Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain

Clinical therapeutics, 2013-05, Vol.35 (5), p.659-672

2013

Volltextzugriff (PDF)

The economic implications of switching to rivaroxaban from enoxaparin plus vitamin K antagonist in the treatment of venous thromboembolism

Journal of medical economics, 2015-05, Vol.18 (5), p.323-332

2015

Volltextzugriff (PDF)

Corrigendum to ‘Inpatient Resource Utilization and Cost Burden of Deep Vein Thrombosis and Pulmonary Embolism in the United States’ Clin Ther 2015;37:62–70

Clinical therapeutics, 2015-10, Vol.37 (10), p.2382-2383

2015

Volltextzugriff (PDF)

Gastrointestinal comorbidities associated with atrial fibrillation

SpringerPlus, 2014-10, Vol.3 (1), p.603-603, Article 603

2014

Volltextzugriff (PDF)

A cost-analysis model for anticoagulant treatment in the hospital setting

Journal of medical economics, 2014-07, Vol.17 (7), p.492-498

2014

Volltextzugriff (PDF)

The economic burden to medicare of stroke events in atrial fibrillation populations with and without thromboprophylaxis

Population health management, 2014-06, Vol.17 (3), p.159-165

2014

Volltextzugriff (PDF)

Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States

Journal of medical economics, 2013-02, Vol.16 (2), p.307-317

2013

Volltextzugriff (PDF)

Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia

Surgical infections, 2010-10, Vol.11 (5), p.409-417

2010

Volltextzugriff (PDF)

Physician management of moderate-to-severe acute pain: results from the Physicians Partnering Against Pain (P³) study

Journal of opioid management, 2013-11, Vol.9 (6), p.401-406

2013

Volltextzugriff (PDF)

122: Use of Epoetin Alfa in Maintaning Hemoglobin Control Through a Software-Based Management Tool in a Community Nephrology Setting

American journal of kidney diseases, 2008, Vol.51 (4), p.B58-B58

2008

Volltextzugriff (PDF)

Opioid utilization patterns among medicare patients with diabetic peripheral neuropathy

American health & drug benefits, 2013-05, Vol.6 (4), p.188-196

2013

Volltextzugriff (PDF)

Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR

American health & drug benefits, 2013-11, Vol.6 (9), p.567-575

2013

Volltextzugriff (PDF)

THE PREVALENCE OF POLYCYTHEMIA IN A CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) COHORT

Chest, 2005-10, Vol.128 (4), p.264S-264S

2005

Volltextzugriff (PDF)

ANEMIA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): ASSOCIATION WITH SUPPLEMENTAL O2 USE AND HOSPITALIZATIONS

Chest, 2005-10, Vol.128 (4), p.264S-264S

2005

Volltextzugriff (PDF)

Anticoagulant use for prevention of stroke in a commercial population with atrial fibrillation

American health & drug benefits, 2012-07, Vol.5 (5), p.291-298

2012

Volltextzugriff (PDF)

Cost analytic model to determine the least costly inpatient erythropoiesis stimulating therapy regimen

The Annals of pharmacotherapy, 2008-01, Vol.42 (1), p.16-23

2008

Volltextzugriff (PDF)

Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations

Drugs & aging, 2006-01, Vol.23 (12), p.969-976

2006

Volltextzugriff (PDF)

Abstract 251: The Economic Implications Of Avoidable Therapeutic Obstacles In The Treatment Of Venous Thromboembolism

Circulation Cardiovascular quality and outcomes, 2014-07, Vol.7 (suppl_1)

2014

Volltextzugriff (PDF)

Abstract P292: The Economic Burden To Medicare Of Stroke Events In Atrial Fibrillation Populations With And Without Treatment

Circulation (New York, N.Y.), 2012-03, Vol.125 (suppl_10)

2012

Volltextzugriff (PDF)

Abstract 83: Self-Reported Characteristics and Caregiving Responsibilities Among Caregivers Supporting Patients with Atrial Fibrillation

Circulation Cardiovascular quality and outcomes, 2012-04, Vol.5 (suppl_1)

2012

Volltextzugriff (PDF)

Abstract 200: Self-Reported Patient Characteristics Among Atrial Fibrillation Patients Naïve to Warfarin Therapy, Lapsed on Warfarin Therapy, or Currently Receiving Warfarin Therapy

Circulation Cardiovascular quality and outcomes, 2012-04, Vol.5 (suppl_1)

2012

Volltextzugriff (PDF)

Abstract 150: Resource Utilization Patterns and Outcomes Among Acute Coronary Syndrome Patients: Findings From a Multi-Payer Analysis

Circulation Cardiovascular quality and outcomes, 2013-05, Vol.6 (suppl_1)

2013

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

GASTROINTESTINAL CONDITIONS AMONG PATIENTS WITH ATRIAL FIBRILLATION

Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism

Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain

The economic implications of switching to rivaroxaban from enoxaparin plus vitamin K antagonist in the treatment of venous thromboembolism

Corrigendum to ‘Inpatient Resource Utilization and Cost Burden of Deep Vein Thrombosis and Pulmonary Embolism in the United States’ Clin Ther 2015;37:62–70

Gastrointestinal comorbidities associated with atrial fibrillation

A cost-analysis model for anticoagulant treatment in the hospital setting

The economic burden to medicare of stroke events in atrial fibrillation populations with and without thromboprophylaxis

Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States

Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia

Physician management of moderate-to-severe acute pain: results from the Physicians Partnering Against Pain (P³) study

122: Use of Epoetin Alfa in Maintaning Hemoglobin Control Through a Software-Based Management Tool in a Community Nephrology Setting

Opioid utilization patterns among medicare patients with diabetic peripheral neuropathy

Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR

THE PREVALENCE OF POLYCYTHEMIA IN A CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) COHORT

ANEMIA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): ASSOCIATION WITH SUPPLEMENTAL O2 USE AND HOSPITALIZATIONS

Anticoagulant use for prevention of stroke in a commercial population with atrial fibrillation

Cost analytic model to determine the least costly inpatient erythropoiesis stimulating therapy regimen

Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations

Abstract 251: The Economic Implications Of Avoidable Therapeutic Obstacles In The Treatment Of Venous Thromboembolism

Abstract P292: The Economic Burden To Medicare Of Stroke Events In Atrial Fibrillation Populations With And Without Treatment

Abstract 83: Self-Reported Characteristics and Caregiving Responsibilities Among Caregivers Supporting Patients with Atrial Fibrillation

Abstract 200: Self-Reported Patient Characteristics Among Atrial Fibrillation Patients Naïve to Warfarin Therapy, Lapsed on Warfarin Therapy, or Currently Receiving Warfarin Therapy

Abstract 150: Resource Utilization Patterns and Outcomes Among Acute Coronary Syndrome Patients: Findings From a Multi-Payer Analysis

Aktive Filter

Suchergebnisse filtern